UNDP, working in partnership with the Global Fund and national partners, has put 2,400 people on antiretroviral therapy for HIV and 3,000 people on treatment for TB.

Key results

Djibouti faces major challenges in tackling HIV and tuberculosis due to weak infrastructure of the national health system, equipment shortages, and scarcity of human resources. In January 2013, UNDP took over the role of Principal Recipient for Global Fund HIV and TB grants. Read more...
Support focuses on the provision of essential HIV and TB services, including expanding access to ART, preventing mother-to-child transmission of HIV, improving TB prevention and diagnosis in high-risk populations, mainly refugees, prisoners and nomadic populations, expanding access to High Quality Directly Observed Treatment Short-course (DOTS) and provision of Multi-Drug Resistant TB treatment. In 2012 Djibouti reached the pre-elimination phase for malaria with just 24 cases reported, but by 2014 it had reached 9,439 cases. UNDP became Principal Recipient for the malaria grant at the beginning of 2016. The programme aims at strengthening the control phase of malaria to reach the pre-elimination phase by 2020. It provides testing, treatment and vector control. Particularly high risk groups are prioritised for targeted bed net distributions, including nomadic, migrant and refugee populations.

22,000 cases of malaria treated

Source: UNDP

85% treatment success rate for TB (2015)

Source: World Health Organization

95% retention on ART 12 months after commencing treatment (2016)

Source: UNAIDS

Maternal and infant mortality rates

Source: World Health Organization

Reported confirmed cases of Malaria

Source: World Health Organization